Structurally distinct cyclosporin and sanglifehrin analogs CRV431 and NV556 suppress established HCV infection in humanized-liver mice

We previously reported that the non-immunosuppressive cyclophilin inhibitors (CypIs)—cyclosporin A analog CRV431 and sanglifehrin analog NV556—efficiently inhibit HCV replication in vitro. In this study, we asked whether they can also reduce HCV replication in vivo. We found that a single oral admin...

Descripción completa

Detalles Bibliográficos
Autores principales: Bobardt, Michael, Hansson, Magnus Joakim, Mayo, Patrick, Ure, Daren, Foster, Robert, Gallay, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7413547/
https://www.ncbi.nlm.nih.gov/pubmed/32764799
http://dx.doi.org/10.1371/journal.pone.0237236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7413547/
https://www.ncbi.nlm.nih.gov/pubmed/32764799
http://dx.doi.org/10.1371/journal.pone.0237236

Ejemplares similares